230 related articles for article (PubMed ID: 37241157)
21. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
22. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer.
Barra F; Leone Roberti Maggiore U; Bogani G; Ditto A; Signorelli M; Martinelli F; Chiappa V; Lorusso D; Raspagliesi F; Ferrero S
J Obstet Gynaecol; 2019 Jan; 39(1):1-10. PubMed ID: 30370796
[TBL] [Abstract][Full Text] [Related]
23. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
Brinkman JA; Caffrey AS; Muderspach LI; Roman LD; Kast WM
Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Selected Properties and Related Cervical Cancer Prevention Issues.
Balmagambetova S; Tinelli A; Mynbaev OA; Koyshybaev A; Urazayev O; Kereyeva N; Ismagulova E
Curr Pharm Des; 2020; 26(18):2073-2086. PubMed ID: 32321395
[TBL] [Abstract][Full Text] [Related]
25. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries.
Wang WV; Kothari S; Khoury H; Niccolai L; Garland SM; Sundström K; de Pouvourville G; Bonanni P; Chen YT; Franco EL
Expert Rev Vaccines; 2023; 22(1):161-179. PubMed ID: 36576068
[TBL] [Abstract][Full Text] [Related]
26. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
27. [Screening for cervical cancer, human papillomavirus (HPV) vaccination].
Schaff Z; Járay B
Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827
[TBL] [Abstract][Full Text] [Related]
28. Impact of HPV vaccination: health gains in the Italian female population.
Marcellusi A
Popul Health Metr; 2017 Sep; 15(1):36. PubMed ID: 28962572
[TBL] [Abstract][Full Text] [Related]
29. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and cost of cervical cancer care and prevention in Apulia (Italy), 2007/2016.
Bianchi FP; Gallone MS; Fortunato F; Boccalini S; Martinelli D; Prato R; Tafuri S
Ann Ig; 2018; 30(6):490-501. PubMed ID: 30614498
[TBL] [Abstract][Full Text] [Related]
31. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Oct; 128(4):e111-e130. PubMed ID: 27661651
[TBL] [Abstract][Full Text] [Related]
32. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
33. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
34. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
[TBL] [Abstract][Full Text] [Related]
35. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
[TBL] [Abstract][Full Text] [Related]
36. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.
Ladner J; Besson MH; Audureau E; Rodrigues M; Saba J
BMC Health Serv Res; 2016 Oct; 16(1):575. PubMed ID: 27737666
[TBL] [Abstract][Full Text] [Related]
37. Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review.
Murfin J; Irvine F; Meechan-Rogers R; Swift A
J Clin Nurs; 2020 Feb; 29(3-4):393-415. PubMed ID: 31713934
[TBL] [Abstract][Full Text] [Related]
38. Preventing Cervical Cancer Globally: Are We Making Progress?
Allanson ER; Schmeler KM
Cancer Prev Res (Phila); 2021 Dec; 14(12):1055-1060. PubMed ID: 34853026
[TBL] [Abstract][Full Text] [Related]
39. The present scenario of cervical cancer control and HPV epidemiology in India: an outline.
Senapathy JG; Umadevi P; Kannika PS
Asian Pac J Cancer Prev; 2011; 12(5):1107-15. PubMed ID: 21875253
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer: A global health crisis.
Small W; Bacon MA; Bajaj A; Chuang LT; Fisher BJ; Harkenrider MM; Jhingran A; Kitchener HC; Mileshkin LR; Viswanathan AN; Gaffney DK
Cancer; 2017 Jul; 123(13):2404-2412. PubMed ID: 28464289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
